Introduction

Promethazine is a first-generation antihistamine of the phenothiazine class, widely used for its antiemetic, sedative, and antiallergic properties. Originally developed in the 1940s, it remains a staple in clinical practice for managing nausea, vomiting, motion sickness, allergies, and as a preoperative sedative. Despite its long history, promethazine carries significant safety considerations, including respiratory depression, extrapyramidal effects, and the risk of misuse. This report examines its pharmacology, therapeutic indications, adverse effects, and clinical guidelines.

Pharmacology and Mechanism of Action

Promethazine primarily acts as a potent antagonist at histamine H1 receptors, thereby inhibiting the effects of histamine released during allergic reactions. It also exhibits anticholinergic activity by blocking muscarinic receptors, contributing to its antiemetic and sedative effects. Additionally, promethazine antagonizes dopamine D2 receptors in the central nervous system, which accounts for its antiemetic properties but also raises the risk of extrapyramidal side effects. Its sedative action is mediated through blockade of histamine and possibly alpha-adrenergic receptors in the brain. The drug is metabolized in the liver via CYP2D6 and other pathways, with an elimination half-life of approximately 10–19 hours.

Therapeutic Indications

Promethazine is approved for several conditions:

• Allergic Conditions: It alleviates symptoms of allergic rhinitis, Help & FAQ urticaria, and pruritus by blocking peripheral H1 receptors. However, its sedative profile limits use to cases where other antihistamines are ineffective or when sedation is desirable.
  
  
• Nausea and Vomiting: It is effective for motion sickness, postoperative nausea, and nausea associated with pregnancy (though caution is advised). It is often used in combination with other antiemetics.
  
  
• Sedation and Preanesthetic Adjunct: Promethazine is used to induce sedation before surgical procedures, reduce anxiety, and potentiate the effects of analgesics.
  
  
• Other Uses: Off-label applications include treatment of vertigo, migraines (as part of combination therapy), and as a short-term hypnotic.
  
  

Promethazine is available in oral tablets, syrups, suppositories, injectable solutions, and topical creams. Oral doses typically range from 12.5 to 25 mg every 4–6 hours for adults, with a maximum of 100 mg daily. For motion sickness, a dose of 25 mg taken 30–60 minutes before travel is common. In children, dosing must be weight-based and cautious, as pediatric patients are more susceptible to respiratory depression. Rectal suppositories are an alternative for those unable to swallow.

Adverse Effects

The most common adverse effects include drowsiness, sedation, dizziness, blurred vision, dry mouth, and constipation—all attributable to its antihistamine and anticholinergic activity. Hypersensitivity reactions, such as rashes and photosensitivity, are less frequent. More serious effects include:

• Respiratory Depression: Especially in children, elderly, or those with respiratory compromise. This risk is heightened when combined with other central nervous system depressants.
  
  
• Extrapyramidal Symptoms: Dystonia, tardive dyskinesia, and parkinsonism can occur, particularly with prolonged use or high doses.
  
  
• Cardiovascular: QT prolongation and arrhythmias have been reported, especially in overdose or individuals with predisposing conditions.
  
  
• Neuroleptic Malignant Syndrome: A rare but life-threatening reaction characterized by fever, rigidity, and autonomic instability.
  
  
• Injection Site Reactions: Pain, necrosis, or abscess formation can occur with intramuscular injection; intravenous administration is contraindicated due to risk of severe local injury.
  
  

Promethazine is contraindicated in patients with known hypersensitivity, severe CNS depression, coma, or in children under two years of age due to risk of fatal respiratory depression. Caution is needed in elderly patients (increased fall risk), those with asthma, glaucoma, prostate hypertrophy, liver impairment, or epilepsy. It should not be used in combination with MAOIs, as anticholinergic effects may be potentiated. During pregnancy, the drug should be used only when clearly needed, as it crosses the placenta; safety in labor and delivery is unclear. Breastfeeding mothers should avoid it due to potential effects on the infant.

Drug Interactions

Additive sedation occurs with alcohol, benzodiazepines, opioids, and other CNS depressants. Anticholinergic effects are increased when combined with tricyclic antidepressants, antispasmodics, or other antihistamines. Promethazine may alter the metabolism of certain drugs (e.g., beta-blockers), and hepatotoxic agents should be used with caution.

Overdose Management

Overdose presents with profound sedation, confusion, hallucinations, seizures, respiratory depression, and severe anticholinergic symptoms (hyperthermia, dry skin, dilated pupils). Cardiovascular toxicity (QT prolongation, arrhythmias) may occur. Management involves supportive care, activated charcoal if early, and symptomatic treatment for seizures or arrhythmias. Physostigmine may reverse anticholinergic delirium but is used with caution due to risk of asystole.

Regulatory Status and Abuse Potential

In some countries, promethazine is a controlled substance due to its sedative effects and potential for misuse, often in combination with opioids (e.g., "purple drank"). Chronic use can lead to tolerance and dependence, but withdrawal is generally mild. Promethazine is available over the counter in some regions for certain indications, but in many places it requires a prescription.

Conclusion

Promethazine remains a valuable medication for nausea, allergies, and sedation when used appropriately. Its safety profile demands careful patient selection, particularly regarding age, respiratory status, and concomitant medications. Clinicians should be aware of its potential for serious adverse effects and abuse, and patients should be counseled against driving or operating machinery while under its influence. As newer antihistamines with fewer central effects become available, promethazine’s role is increasingly reserved for situations requiring its sedative or strong antiemetic action.